Neurorehabilitation Devices Market Value Anticipated To Reach US$ 3,476.3 Million By 2027: Acumen Research and Consulting
05 févr. 2021 11h02 HE
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Neurorehabilitation Devices Market– Global Industry Analysis, Market Size,...
Brain Scientific Unveils New Initiative to Develop Brain E-Tattoo Device for the Brain Diagnostics Market
21 janv. 2021 08h30 HE
|
Brain Scientific Inc.
Powered by A.I., Brain E-Tattoo Technology is Expected to Provide Continuous Monitoring for Uninterrupted Data Collection in Patients with Epilepsy, Alzheimer’s, Stroke, and More. NEW YORK, Jan. 21,...
Deep Brain Stimulation Devices Market Expected To Rise Significantly By 2025, Estimates DelveInsight
05 janv. 2021 09h30 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Deep Brain Stimulation Devices Market Expected To Rise Significantly By 2025, Estimates DelveInsight DelveInsight predicts a favorable growth...
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent FDA Approval of IND Application
28 déc. 2020 08h00 HE
|
CNS Pharmaceuticals, Inc.
HOUSTON, Dec. 28, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary...
Brain Scientific To Enter the U.S. Pediatric Market with NeuroCap™ for Children
17 déc. 2020 08h30 HE
|
Brain Scientific Inc.
NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, has announced its next generation...
InvestorBrandNetwork Announces ‘Want Money Got Money’ Podcast with CNS Pharmaceuticals Inc. Chairman and CEO John Climaco
16 déc. 2020 08h30 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Dec. 16, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...
Brain Scientific, Creator of Next Gen Neurology Technologies, Announces Regulation A+ Offering
15 déc. 2020 08h30 HE
|
Brain Scientific Inc.
NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, today announced it has launched a...
Karamedica Announces National Institute on Aging Grant to Continue Development of Microparticle Therapy for Cerebral Amyloid Angiopathy
15 déc. 2020 07h55 HE
|
Karamedica, Inc.
RALEIGH, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Karamedica, Inc. recently received a $2.5 million Small Business Innovative Research (SBIR) Phase II grant from the National Institute on Aging to...
Global Cancer Stem Cells Market to Boost with CAGR of 11.8% and Cross a Margin of $1,898.3 Million During the Covid-19 Outbreak – Exclusive Report [150 Pages] by Research Dive
08 déc. 2020 09h05 HE
|
Research Dive
New York, USA, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The cancer stem cells market is anticipated to grow rapidly in the Covid-19 outbreak due to usage of cancer stem cells for treating cancer. According...
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements for Glioblastoma Multiforme (GBM) Therapy
24 nov. 2020 08h00 HE
|
CNS Pharmaceuticals, Inc.
HOUSTON, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary...